UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.78 +0.76 (+0.97%) GOLD FUTURES
2,392.30 +32.40 (+1.37%) DOW
39,865.22 +307.11 (+0.78%) Bitcoin GBP
52,056.48 +3,521.09 (+7.25%)
Pharvaris N.V. (PHVS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:36PM EDT. Market open.
| Previous close | 20.80 |
| Open | 21.10 |
| Bid | 21.84 x 100 |
| Ask | 23.21 x 100 |
| Day's range | 21.10 - 23.07 |
| 52-week range | 8.20 - 33.00 |
| Volume | |
| Avg. volume | 72,965 |
| Market cap | 1.232B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Zacks
Pharvaris (PHVS) Up as FDA Lifts Clinical Hold on HAE Program
Pharvaris (PHVS) rises 6% after the FDA lifts the clinical hold on the investigational candidate, deucrictibant, for the prophylactic treatment of HAE attacks.
- Simply Wall St.
Pharvaris N.V.'s (NASDAQ:PHVS) largest shareholders are private equity firms who were rewarded as market cap surged US$578m last week
Key Insights Significant control over Pharvaris by private equity firms implies that the general public has more power...
© 2024 Yahoo. All rights reserved.